Статті в журналах з теми "Y220C"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Y220C".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Gener-Ricos, Georgina, Jan Philipp Bewersdorf, Sanam Loghavi, Aaron D. Goldberg, Christopher Famulare, Ghayas C. Issa, Gautam Borthakur, et al. "TP53 Y220C Mutations in Patients with Myeloid Malignancies." Blood 142, Supplement 1 (November 28, 2023): 1477. http://dx.doi.org/10.1182/blood-2023-189343.
Carter, Bing Z., Po Yee Mak, Baozhen Ke, Yuki Nishida, Steffen Boettcher, Andrea Bedoy, Lauren B. Ostermann, et al. "Selective Targeting of TP53-Y220C Mutant AML By PC14586 Results in TP53 Wild-Type Conformation and Synergistical Apoptosis Induction By Concomitant Inhibition of Xpo-1, MDM2, or Bcl-2." Blood 142, Supplement 1 (November 28, 2023): 2261. http://dx.doi.org/10.1182/blood-2023-181186.
Puzio-Kuter, Anna M., Chris Mulligan, Brandon Russo, Amy Wiebesiek, Lizhong Xu, Hong Yang, Binh Vu, and Melissa Dumble. "Abstract 1295: Small molecule reactivators of Y220C mutant p53 modulate tumor infiltrating leukocytes and synergize with immune checkpoint inhibitors." Cancer Research 82, no. 12_Supplement (June 15, 2022): 1295. http://dx.doi.org/10.1158/1538-7445.am2022-1295.
Zheng, Qian, Peng Wang, Chen Liang, Yao Li, Xin Sun, Amin Li, Wei Zhang, Wei Long, and Yanping Wang. "Abstract 5940: JAB-30355: A highly potent, orally bioavailable p53-Y220C reactivator." Cancer Research 84, no. 6_Supplement (March 22, 2024): 5940. http://dx.doi.org/10.1158/1538-7445.am2024-5940.
Liu, Meng, Kaijun Geng, Biao Lu, Yuanfeng Xia, and Fanglong Yang. "Abstract 7275: GS-P-328, a brain-penetrant small molecule p53 Y220C reactivator for tumors harboring p53 Y220C mutation." Cancer Research 84, no. 6_Supplement (March 22, 2024): 7275. http://dx.doi.org/10.1158/1538-7445.am2024-7275.
Valenzuela-Chavira, Ignacio, Salvador Meneses-Sagrero, Aldo A. Arvizu-Flores, Javier Hernández-Paredes, Luisa Rascón-Valenzuela, Carlos A. Velázquez-Contreras, and Ramón E. Robles-Zepeda. "Molecular Docking of the Cardenolides of Asclepias subulata in the Human p53 Protein Reveals an Interaction in the Cleft of the Y220C Mutant." Current Chemical Biology 15, no. 3 (September 2021): 222–33. http://dx.doi.org/10.2174/2212796815666211026112056.
Bauer, Matthias R., Rhiannon N. Jones, Raysa K. Tareque, Bradley Springett, Felix A. Dingler, Lorena Verduci, Ketan J. Patel, Alan R. Fersht, Andreas C. Joerger, and John Spencer. "A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C." Future Medicinal Chemistry 11, no. 19 (October 2019): 2491–504. http://dx.doi.org/10.4155/fmc-2019-0181.
Baud, Matthias G. J., Matthias R. Bauer, Lorena Verduci, Felix A. Dingler, Ketan J. Patel, Deeptee Horil Roy, Andreas C. Joerger, and Alan R. Fersht. "Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines." European Journal of Medicinal Chemistry 152 (May 2018): 101–14. http://dx.doi.org/10.1016/j.ejmech.2018.04.035.
Schram, Alison M., Geoffrey I. Shapiro, Melissa L. Johnson, Anthony W. Tolcher, John A. Thompson, Anthony B. El-Khoueiry, Andrae L. Vandross, et al. "Abstract LB_A25: Updated Phase 1 results from the PYNNACLE Phase 1/2 study of PC14586, a selective p53 reactivator, in patients with advanced solid tumors harboring a TP53 Y220C mutation." Molecular Cancer Therapeutics 22, no. 12_Supplement (December 1, 2023): LB_A25. http://dx.doi.org/10.1158/1535-7163.targ-23-lb_a25.
Lane, David P., and Chandra S. Verma. "Covalent Rescue of Mutant p53." Cancer Discovery 13, no. 1 (January 9, 2023): 14–16. http://dx.doi.org/10.1158/2159-8290.cd-22-1212.
Rockwell, Nathan, Nicole Warrington, and Joshua Rubin. "CBIO-22. p53 GAIN-OF-FUNCTION MUTATIONS DRIVE SEX SPECIFIC EFFECTS ON GLIOMA TUMORIGENESIS." Neuro-Oncology 22, Supplement_2 (November 2020): ii20. http://dx.doi.org/10.1093/neuonc/noaa215.082.
Gomes, Sara, Bartolomeo Bosco, Joana B. Loureiro, Helena Ramos, Liliana Raimundo, Joana Soares, Nair Nazareth, et al. "SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma." Cancers 11, no. 8 (August 10, 2019): 1151. http://dx.doi.org/10.3390/cancers11081151.
Gori, M., B. Barbaro, R. Maggio, M. Arciello, C. Viscomi, and C. Balsano. "Protective effect of the Y220C mutant p53 during steatosis: Good news?" Digestive and Liver Disease 45 (October 2013): e368-e369. http://dx.doi.org/10.1016/j.dld.2013.09.010.
Miller, Jessica J., Christophe Orvain, Shireen Jozi, Ryan M. Clarke, Jason R. Smith, Anaïs Blanchet, Christian Gaiddon, Jeffrey J. Warren, and Tim Storr. "Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer." Chemistry - A European Journal 24, no. 67 (November 9, 2018): 17734–42. http://dx.doi.org/10.1002/chem.201802677.
Gori, Manuele, Barbara Barbaro, Mario Arciello, Roberta Maggio, Carmela Viscomi, Alessia Longo, and Clara Balsano. "Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News?" Journal of Cellular Physiology 229, no. 9 (May 23, 2014): 1182–92. http://dx.doi.org/10.1002/jcp.24550.
Gori, M., B. Barbaro, M. Arciello, R. Maggio, C. Viscomi, A. Longo, and C. Balsano. "Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News?" Journal of Cellular Physiology 230, no. 6 (February 25, 2015): 1400. http://dx.doi.org/10.1002/jcp.24874.
Dixit, Updesh, Ashutosh K. Pandey, Zhihe Liu, Sushil Kumar, Matthew B. Neiditch, Kenneth M. Klein, and Virendra N. Pandey. "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53." Journal of Virology 89, no. 15 (May 20, 2015): 7905–21. http://dx.doi.org/10.1128/jvi.00729-15.
Gener-Ricos, Georgina, Koji Sasaki, Sanam Loghavi, Abhishek Maiti, Nicholas Short, Fadi Haddad, Naval Daver, et al. "A Descriptive Analysis of TP53 Y220C Mutations in Patients with Hematologic Malignancies." Blood 140, Supplement 1 (November 15, 2022): 11830–32. http://dx.doi.org/10.1182/blood-2022-167923.
Rauf, Shah Md Abdur, Akira Endou, Hiromitsu Takaba, and Akira Miyamoto. "Effect of Y220C Mutation on p53 and Its Rescue Mechanism: A Computer Chemistry Approach." Protein Journal 32, no. 1 (January 2013): 68–74. http://dx.doi.org/10.1007/s10930-012-9458-x.
SHEN, Hong-Chen, Ji-Yong DING, Li LI, and Fu-Feng LIU. "Effect of Y220C Mutant on the Conformational Transition of p53C Probed by Molecular Dynamics Simulation." Acta Physico-Chimica Sinica 32, no. 10 (2016): 2620–27. http://dx.doi.org/10.3866/pku.whxb201606224.
van Kempen, Pauline M. W., Froukje J. Verdam, Eyleen de Poel, Weibel W. Braunius, Roel A. de Weger, Robert J. J. van Es, Wilko Grolman, and Stefan M. Willems. "TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma." Pathobiology 82, no. 1 (2015): 21–27. http://dx.doi.org/10.1159/000369102.
Khadiullina, Raniya, Regina Mirgayazova, Damir Davletshin, Elvina Khusainova, Vitaly Chasov, and Emil Bulatov. "Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry." Life 13, no. 1 (December 22, 2022): 31. http://dx.doi.org/10.3390/life13010031.
Bauer, Matthias R., Rhiannon N. Jones, Matthias G. J. Baud, Rainer Wilcken, Frank M. Boeckler, Alan R. Fersht, Andreas C. Joerger, and John Spencer. "Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs." ACS Chemical Biology 11, no. 8 (June 21, 2016): 2265–74. http://dx.doi.org/10.1021/acschembio.6b00315.
Accordino, Sebastián R., J. Ariel Rodríguez Fris, and Gustavo A. Appignanesi. "Wrapping Effects within a Proposed Function-Rescue Strategy for the Y220C Oncogenic Mutation of Protein p53." PLoS ONE 8, no. 1 (January 24, 2013): e55123. http://dx.doi.org/10.1371/journal.pone.0055123.
Basse, Nicolas, Joel L. Kaar, Giovanni Settanni, Andreas C. Joerger, Trevor J. Rutherford, and Alan R. Fersht. "Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant." Chemistry & Biology 17, no. 1 (January 2010): 46–56. http://dx.doi.org/10.1016/j.chembiol.2009.12.011.
Shokat, Kevan M. "Abstract IA08: Direct covalent inhibitors of mutant K-Ras." Molecular Cancer Research 21, no. 5_Supplement (May 1, 2023): IA08. http://dx.doi.org/10.1158/1557-3125.ras23-ia08.
Yu, Camilla, Aaron Petty, and Roberto Vargas. "Abstract 4885: APR-246 cytotoxic effects are TP53 independent in endometrial cancer cell lines." Cancer Research 83, no. 7_Supplement (April 4, 2023): 4885. http://dx.doi.org/10.1158/1538-7445.am2023-4885.
Ahire, Vidhula, D. Das, Kaushala Prasad Mishra, G. R. Kulkarni, and L. Ackland. "Inhibition of the p53 Y220C Mutant by 1-Hydroxy-2- Methylanthraquinone Derivatives: A Novel Strategy for Cancer Therapy." Journal of Environmental Pathology, Toxicology and Oncology 35, no. 4 (2016): 355–64. http://dx.doi.org/10.1615/jenvironpatholtoxicoloncol.2016012256.
Bromley, Dennis, Matthias R. Bauer, Alan R. Fersht, and Valerie Daggett. "Anin silicoalgorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein." Protein Engineering Design and Selection 29, no. 9 (August 8, 2016): 377–90. http://dx.doi.org/10.1093/protein/gzw035.
Luparello, Claudio, Ilenia Cruciata, Andreas C. Joerger, Cory A. Ocasio, Rhiannon Jones, Raysa Khan Tareque, Mark C. Bagley, et al. "Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells." International Journal of Molecular Sciences 22, no. 7 (March 26, 2021): 3410. http://dx.doi.org/10.3390/ijms22073410.
Bhuvaneshwari, C., and S. Ambiga. "Antioxidant and anticancer activities of Solanum nigrum Linn leaves." Journal of Current Opinion in Crop Science 3, no. 2 (June 28, 2022): 79–89. http://dx.doi.org/10.62773/jcocs.v3i2.171.
Arciello, Mario, Alessia Longo, Carmela Viscomi, Concetta Capo, Antonio Angeloni, Luisa Rossi, and Clara Balsano. "Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload." BioMetals 28, no. 6 (October 5, 2015): 1017–29. http://dx.doi.org/10.1007/s10534-015-9886-0.
Tseng, Tsui-Hwa, Chau-Jong Wang, Yean-Jang Lee, Yi-Chia Shao, Chien-Heng Shen, Ko-Chao Lee, Shui-Yi Tung, and Hsing-Chun Kuo. "Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol." International Journal of Molecular Sciences 23, no. 9 (May 4, 2022): 5102. http://dx.doi.org/10.3390/ijms23095102.
Tseng, Tsui-Hwa, Yi-Chia Shao, Yean-Jang Lee, and Huei-Jane Lee. "2-(4-Benzyloxy-3-methoxyphenyl)-5-(carbethoxyethylene)-7-methoxy-benzofuran, a Benzofuran Derivative, Suppresses Metastasis Effects in P53-Mutant Hepatocellular Carcinoma Cells." Biomedicines 11, no. 7 (July 19, 2023): 2027. http://dx.doi.org/10.3390/biomedicines11072027.
Lv, Cuiting, Aihua Lan, Xiao Fan, Caiguo Huang, and Gong Yang. "Asperolide A induces apoptosis and cell cycle arrest of human hepatoma cells with p53-Y220C mutant through p38 mediating phosphorylation of p53 (S33)." Heliyon 9, no. 3 (March 2023): e13843. http://dx.doi.org/10.1016/j.heliyon.2023.e13843.
Cheng, Ya-Yun, Denise Prosser, Liudmila Velikokhatnaya, and Anna Lokshin. "Abstract 5833: Functional characterization of TP53 mutations in human fallopian tube secretory epithelial cells." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5833. http://dx.doi.org/10.1158/1538-7445.am2022-5833.
Petty, Aaron, Arda Durmaz, Brian Yard, Jacob Scott, and Roberto Vargas. "Abstract 1090: Dominant-negative TP53 variants confer radiation resistance in endometrial cancer." Cancer Research 83, no. 7_Supplement (April 4, 2023): 1090. http://dx.doi.org/10.1158/1538-7445.am2023-1090.
Yang, Yaxian, Heran Wang, Lucas Wang, WenTao Fan, Bin Lian, Ying Jin, Weiquan Luo, et al. "Frequency and patterns of TP53 mutations in lung cancer." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): e21013-e21013. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21013.
Babatunde, Olayode, Ryan Quin Notti, and William D. Tap. "Characterizing TP53 mutations in bone and soft tissue sarcoma." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): e23521-e23521. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e23521.
Moses, Renyta, Ryan Hausler, Gregory Kelly, Alexandra Indeglia, Sven Miller, John Karanicolas, Maureen Murphy, and Kara Maxwell. "Abstract 3025: Germline p53 R181 variants and DNA binding cooperativity in tumorigenesis." Cancer Research 84, no. 6_Supplement (March 22, 2024): 3025. http://dx.doi.org/10.1158/1538-7445.am2024-3025.
Nesline, Mary K., Paul DePietro, Maureen Cooper, Shengle Zhang, Sarah Howarth, Zachary D. Wallen, Michael D. Biorn, et al. "The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): 6506. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.6506.
Battaglin, Francesca, Andrew Elliott, Joanne Xiu, Sandra Algaze, Jingyuan Wang, Priya Jayachandran, Shivani Soni, et al. "Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC)." Journal of Clinical Oncology 42, no. 3_suppl (January 20, 2024): 552. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.552.
Steinbuck, Martin P., Xavier Cabana-Puig, Erica Palmer, Mimi M. Jung, Thomas Williams, Kristen Osaer, Jeff Zhang, Christopher M. Haqq, and Peter C. DeMuth. "Abstract 4099: AMP-peptide vaccination against multiple p53 mutant epitopes promotes lymph node delivery to generate potent, functional T cell immunity." Cancer Research 84, no. 6_Supplement (March 22, 2024): 4099. http://dx.doi.org/10.1158/1538-7445.am2024-4099.
Suehnholz, Sarah P., Moriah Nissan, Hongxin Zhang, Ritika Kundra, Calvin Lu, Amanda Dhaneshwar, Nicole Fernandez, et al. "Abstract 6585: OncoKB, MSK’s precision oncology knowledge base." Cancer Research 83, no. 7_Supplement (April 4, 2023): 6585. http://dx.doi.org/10.1158/1538-7445.am2023-6585.
Kim, Peter, Parisa Malekzadeh, Nolan Vale, Elizabeth Hedges, Nikolaos Zacharakis, and Steven Rosenberg. "152 Adoptive T cell therapy targeting somatic p53 mutations." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A165—A166. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0152.
Van Alsten, Sarah, Ebonee Butler, Benjamin Calhoun, Michael Love, Charles Perou, Katherine A. Hoadley, and Melissa Troester. "Abstract PO1-08-12: Genomic Characterization of the Carolina Breast Cancer Study." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO1–08–12—PO1–08–12. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-08-12.
Deb, S., S. Bandyopadhyay, and S. Roy. "Spectroscopic study of Y210C lambda-repressor: implications for cooperative interaction." Protein Engineering Design and Selection 11, no. 6 (June 1, 1998): 481–87. http://dx.doi.org/10.1093/protein/11.6.481.
Демидова, Т. Е., И. Н. Чижевская, and А. Е. Чижевский. "Formation of historical memory of students by means of network project activities." Management of Education 14, no. 1-1(74) (January 15, 2024): 165–74. http://dx.doi.org/10.25726/y2202-2949-1521-f.
Bauer, Matthias R., Andreas Krämer, Giovanni Settanni, Rhiannon N. Jones, Xiaomin Ni, Raysa Khan Tareque, Alan R. Fersht, John Spencer, and Andreas C. Joerger. "Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm." ACS Chemical Biology 15, no. 3 (January 28, 2020): 657–68. http://dx.doi.org/10.1021/acschembio.9b00748.
Carter, Bing Z., Po Yee Mak, Wenjing Tao, Lauren B. Ostermann, Steffen Boettcher, Yuki Nishida, Edward Ayoub, et al. "Combined Inhibition of Bcl-2 and Mcl-1 Circumvents Resistance of TP53 Deficient/Mutant AML to BH3 Mimetics." Blood 138, Supplement 1 (November 5, 2021): 2239. http://dx.doi.org/10.1182/blood-2021-148014.